Richard Shelby actually said...

"Unfortunately, Dodd-Frank provides little guidance on exactly which firms should be designated for systemic risk regulation."

"I believe the need for an entity to straddle the world's research and industry is clear."

"As research becomes more expensive and private capital dries up, I believe it's critical to ensure support for translational research."

"We would all benefit from that, wouldn't we?"